Redhill Biopharma
RDHL
22 hedge funds and large institutions have $36.9M invested in Redhill Biopharma in 2015 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 6 increasing their positions, 0 reducing their positions, and 4 closing their positions.
100% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 4
74% more capital invested
Capital invested by funds: $21.2M → $36.9M (+$15.7M)
22% more funds holding
Funds holding: 18 → 22 (+4)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VAM
Visium Asset Management
New York
|
+$7.4M |
| 2 |
BC
Broadfin Capital
New York
|
+$6.6M |
| 3 |
AIC
AWM Investment Company
New York
|
+$4M |
| 4 |
MMH
Menora Mivtachim Holdings
Ramat Gan,
Israel
|
+$3.64M |
| 5 |
SM
Sabby Management
Miami Beach,
Florida
|
+$2.58M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$472K |
| 2 |
LWM
Lyons Wealth Management
Winter Park,
Florida
|
-$203K |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$163K |
| 4 |
SFPIA
Stevens First Principles Investment Advisors
Newport Beach,
California
|
-$9K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
26
Renaissance Technologies
New York
| – | -$472K | -27 | Closed |
|
|
LWM
27
Lyons Wealth Management
Winter Park,
Florida
| – | -$203K | -12 | Closed |
|
|
SFPIA
28
Stevens First Principles Investment Advisors
Newport Beach,
California
| – | -$9K | -1 | Closed |
|
RDHL Hedge Fund Activity: Q3 2015 in Review
22 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Redhill Biopharma (RDHL) for Q3 2015, worth a combined $36.9M — up 74% from $21.2M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new RDHL positions and 4 closed out — a net gain of 4 holders — while 6 added to existing stakes and 0 trimmed.
The largest buyer was Visium Asset Management, opening a new position worth an estimated $7.4M. The largest seller was Renaissance Technologies, exiting entirely with an estimated $472K sold.
- 22 institutional investors held Redhill Biopharma (RDHL) as of Q3 2015, up from 18 in Q2 2015.
- Funds reported $36.9M of Redhill Biopharma stock for Q3 2015, up 74% quarter-over-quarter.
- 8 funds opened new Redhill Biopharma positions in Q3 2015 and 4 closed out, a net change of +4 holders.
- The largest Redhill Biopharma buyer in Q3 2015 was Visium Asset Management, an estimated $7.4M added.
- The largest Redhill Biopharma seller in Q3 2015 was Renaissance Technologies, an estimated $472K sold.
Based on aggregated 13F filings for Q3 2015.